TXT In plain English
Company description
ROCHE PRODUCTS LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 14 December 1908; registered for 117 years; registered office reported in WELWYN GARDEN CITY. Its primary declared activity is 46460 · Wholesale of pharmaceutical goods, with 1 additional SIC activity reported.
This BritDB profile also contains linked public records: 1 PSC record, 30 trade marks, 18 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- ROCHE PRODUCTS LIMITED
- Company number
- 00100674
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 0 total · 0 outstanding · 0 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
31 December 2024Next accounts due
30 September 2026Last statement made up to
29 April 2026Next statement due
13 May 2027BritDB does not infer overdue status when the source does not state it.
03 Workforce reporting
Gender pay gap
- Median bonus gap
- 8.9%
- Mean bonus gap
- 21.3%
- Women receiving bonus
- 98.3%
- Men receiving bonus
- 97.9%
- Women in top quartile
- 48.3%
- Women in upper middle quartile
- 63.4%
- Women in lower middle quartile
- 67.4%
- Women in lower quartile
- 68.8%
Earlier reporting years (8)
- 1000 to 49996.9% median hourly gap
- 1000 to 49995.9% median hourly gap
- 1000 to 49997.8% median hourly gap
- 1000 to 49999.3% median hourly gap
- 1000 to 49998.7% median hourly gap
- 1000 to 49999.2% median hourly gap
- 1000 to 49999.5% median hourly gap
- 1000 to 499910.6% median hourly gap
Positive gaps mean men were paid more; negative gaps mean women were paid more. These figures are employer-reported and describe the workforce distribution, not equal pay for the same job. The company link uses the exact Companies House number supplied by the service.
04 Supplier payments
Payment practices and performance
- Reporting period
- 1 January 2026 – 30 June 2026
- Filed
- 3 August 2026
- Shortest standard term
- 0 days
- Longest standard term
- 120 days
- E-invoicing offered
- Yes
- Supply-chain finance
- Offered
- Payment codes
- No
- Construction retentions
- No qualifying construction contracts
Complete reported payment fields
- Policy regime
- Regime-3
- Financial period started
- 1 January 2026
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid within 30 days
- £328,707,016
- Invoice value paid in 31–60 days
- £210,387,225
- Invoice value paid after 60 days
- £101,156,019
- Invoice value paid outside agreed terms
- £292,572,444
- Invoices paid in 31–60 days
- 54.0%
- Invoices unpaid due to dispute
- 0.0%
- Maximum contractual payment period
- 120 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Maximum contractual payment information
n/a
Reported terms and dispute process
- Standard payment terms
0 days
14 days
30 days
45 days
60 days
75 days
90 days
120 days - Other payment-term information
n/a
- Dispute resolution process
1) Disputed invoices are queried with the supplier immediately after the discrepancy is noticed. Most common queries are in relation to pricing, quantities and missing purchase order numbers. Queries are made in writing and list the type of query and all the required details. The invoices are then held pending resolution. This process is owned by our Accounts payable team.
2) Accounts payable deal with the supplier responses and process credit notes to release invoice payments.
3) Accounts payable liaise with internal points of contact to get the queries resolved as soon as possible.
4) Accounts payable liaise with suppliers to obtain and process any missing invoices and to confirm payment details.
Earlier payment reports (10 shown)
- 49.0 average days to pay6.0% outside terms
- 43.0 average days to pay9.0% outside terms
- 50.0 average days to pay36.0% outside terms
- 43.0 average days to pay19.0% outside terms
- 32.0 average days to pay7.0% outside terms
- 39.0 average days to pay6.0% outside terms
- 35.0 average days to pay10.0% outside terms
- 35.0 average days to pay9.0% outside terms
- 35.0 average days to pay12.0% outside terms
- 36.0 average days to pay12.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
05 Supply-chain transparency
Modern slavery statement
- Organisation
- ROCHE PRODUCTS LIMITED
- Group submission
- Yes
- Statement period
- 1 January 2025 – 31 December 2025
- Approved
- 26 May 2026
- Sectors
- Healthcare and pharmaceuticals
Organisation structure
Covered in the statement
Policies
Covered in the statement
Risk assessment
Covered in the statement
Due diligence
Covered in the statement
Training
Covered in the statement
Goals and KPIs
Not reported as covered
Full statement information supplied to the registry
- Reported turnover band
- Over £500 million
- Years producing statements
- More than 5 years
- ILO indicators included
- Not answered
- Registry record updated
- 17 June 2026
Policies described
Freedom of workers to terminate employment Freedom of movement Freedom of association Prohibits any threat of violence, harassment and intimidation Prohibits the use of worker-paid recruitment fees Prohibits compulsory overtime Prohibits child labour Prohibits discrimination Prohibits confiscation of workers' original identification documents Provides access to remedy, compensation and justice for victims of modern slavery
Worker engagement and working conditions
Your suppliers Workers within your organisation
Social audits
Audit conducted by your staff Third party audit arranged by your organisation
Grievance mechanisms
Using anonymous whistleblowing services, such as a helpline or mobile phone app
A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.
06 Data protection
ICO fee-payer registration
Roche Products Limited
Registration Z5689542
- Registered from
- 3 September 2001
- Current end date
- 2 September 2027
This is a candidate association, not an official Companies House link. The ICO file supplies no company number. The organisation name and postcode uniquely matched this company in the current snapshot. BritDB excludes all DPO contact fields and does not publish unmatched personal entries.
07 Public procurement
Contracts Finder awards
REGN-COV2 SUPPLY AGREEMENT FOR PANDEMIC PURPOSES
Business Energy and Industrial Strategy · ocds-b5fd17-808eefe6-4110-42b8-8b0d-4a49deb28d40
- Supplier named in award
- ROCHE PRODUCTS LIMITED
- Award value
- £1
- Contract period
- 5 March 2021 – 31 October 2022
- Published
- 9 March 2022
- Procedure
- Single tender action (below threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-808eefe6-4110-42b8-8b0d-4a49deb28d40-2022-03-09T17:10:40Z
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche
NHS England · ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9
- Supplier named in award
- Roche Products Ltd
- Award value
- £1
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 13 May 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9-2021-05-13T10:21:38+01:00
NHS Framework for the Midlands and East, Branded Medicines - Tranche B
NHS England · ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef
- Supplier named in award
- Roche Products Ltd
- Award value
- £228,156,862
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 30 April 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef-2021-04-30T13:00:26+01:00
NHS Framework for the NHS London Region, Branded Medicines - Tranche A
NHS England · ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67
- Supplier named in award
- Roche Products Limited
- Award value
- £191,062,951
- Contract period
- 1 September 2020 – 31 August 2022
- Published
- 15 September 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67-2020-09-15T14:26:04+01:00
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A
NHS England · ocds-b5fd17-1babd75c-bccc-4e92-ae60-e9319f60f432
- Supplier named in award
- Roche Products Ltd
- Award value
- £334,400,000
- Contract period
- 1 July 2020 – 30 June 2022
- Published
- 3 July 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1babd75c-bccc-4e92-ae60-e9319f60f432-2020-07-03T15:59:42+01:00
NHS Framework Agreement - North of England - Tranche B
NHS England · ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef
- Supplier named in award
- ROCHE PRODUCTS LIMITED
- Award value
- £205,535,556
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 25 March 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef-2020-03-25T08:39:13Z
NHS Midlands and East Branded Medicines - Tranche A
NHS England · ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8
- Supplier named in award
- Roche Products Ltd
- Award value
- £418,787,000
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 13 February 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8-2020-02-13T09:40:57Z
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice
NHS England · ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349
- Supplier named in award
- ROCHE PRODUCTS LIMITED
- Award value
- £188,004,961
- Contract period
- 1 September 2019 – 31 August 2021
- Published
- 17 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349-2019-10-17T10:16:17+01:00
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
NHS England · ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a
- Supplier named in award
- Roche Products Ltd
- Award value
- £251,930,337
- Contract period
- 1 September 2019 – 31 August 2020
- Published
- 1 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a-2019-10-01T15:57:02+01:00
NHS Framework Agreement for Branded Medicines - National
NHS England · ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7
- Supplier named in award
- Roche Products Ltd
- Award value
- £1,351,341,890
- Contract period
- 1 May 2019 – 30 April 2021
- Published
- 9 August 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7-2019-08-09T15:57:38+01:00
Antivirals for use in an influenza pandemic, or wide scale epidemic
DEPARTMENT OF HEALTH · ocds-b5fd17-cd487822-66ab-4780-bed3-67ae8c3ef92f
- Supplier named in award
- ROCHE PRODUCTS LIMITED
- Award value
- £0
- Contract period
- 21 September 2018 – 30 September 2021
- Published
- 5 November 2018
- Procedure
- Competitive procedure with negotiation (above threshold)
- Main CPV
- 33651400
- Source release ID
- ocds-b5fd17-cd487822-66ab-4780-bed3-67ae8c3ef92f-2018-11-05T10:59:11Z
NHS England Framework Agreement: South of England (Tranche B)
NHS England · ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5
- Supplier named in award
- Roche Products Ltd
- Award value
- £501,400,000
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 1 October 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5-2018-10-01T08:55:31+01:00
NHS England Framework Agreement - London - Tranche A
NHS England · ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351
- Supplier named in award
- Roche Products Ltd
- Award value
- £211,435,404
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 7 November 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351-2018-11-07T09:28:44Z
NHS Framework Agreement for Trastuzumab Injection
NHS England · ocds-b5fd17-b6a072b1-6044-401b-8e44-c5d6a74b23ff
- Supplier named in award
- Roche Products Ltd
- Award value
- £226,961,206.42
- Contract period
- 16 July 2018 – 31 August 2019
- Published
- 11 September 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-b6a072b1-6044-401b-8e44-c5d6a74b23ff-2018-09-11T10:15:23+01:00
The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.
TM UK trade marks
Exact owner-name matches
AMPLITAQ TWELVE PAQ
Owner Roche Products Limited · classes 1
- Filed / designated
- 4 September 1992
- Valid until / renewal due
- 4 September 2019
AMPLICOR
Owner Roche Products Limited · classes 1
- Filed / designated
- 6 August 1992
- Valid until / renewal due
- 6 August 2019
AMPERASE
Owner Roche Products Limited · classes 1
- Filed / designated
- 29 June 1992
- Valid until / renewal due
- 29 June 2019
COBAS INTEGRA
Owner Roche Products Limited · classes 1
- Filed / designated
- 22 May 1992
- Valid until / renewal due
- 22 May 2019
COBAS INTEGRA
Owner Roche Products Limited · classes 9
- Filed / designated
- 22 May 1992
- Valid until / renewal due
- 22 May 2019
COBAS INTEGRA
Owner Roche Products Limited · classes 10
- Filed / designated
- 22 May 1992
- Valid until / renewal due
- 22 May 2019
COBAS
Owner Roche Products Limited · classes 1
- Filed / designated
- 16 July 1991
- Valid until / renewal due
- 16 July 2018
AMPLITAQ
Owner Roche Products Limited · classes 1
- Filed / designated
- 8 November 1988
- Valid until / renewal due
- 8 November 2025
VASCACE
Owner Roche Products Limited · classes 5
- Filed / designated
- 27 June 1986
- Valid until / renewal due
- 27 June 2027
ROFERON
Owner Roche Products Limited · classes 5
- Filed / designated
- 11 November 1982
- Valid until / renewal due
- 11 November 2023
LARIAM
Owner Roche Products Limited · classes 5
- Filed / designated
- 13 October 1979
- Valid until / renewal due
- 13 October 2020
ROACCUTANE
Owner Roche Products Limited · classes 5
- Filed / designated
- 3 September 1979
- Valid until / renewal due
- 3 September 2020
ROCALTROL
Owner Roche Products Limited · classes 5
- Filed / designated
- 17 August 1977
- Valid until / renewal due
- 17 August 2018
COBAS
Owner Roche Products Limited · classes 9
- Filed / designated
- 30 April 1974
- Valid until / renewal due
- 30 April 2025
COBAS
Owner Roche Products Limited · classes 10
- Filed / designated
- 30 April 1974
- Valid until / renewal due
- 30 April 2025
ABUSCREEN
Owner Roche Products Limited · classes 1
- Filed / designated
- 17 August 1972
- Valid until / renewal due
- 17 August 2027
MADOPAR
Owner Roche Products Limited · classes 5
- Filed / designated
- 7 July 1970
- Valid until / renewal due
- 7 July 2025
ROCHE
Owner Roche Products Limited · classes 1
- Filed / designated
- 13 May 1970
- Valid until / renewal due
- 13 May 2025
ROCHE
Owner Roche Products Limited · classes 10
- Filed / designated
- 13 May 1970
- Valid until / renewal due
- 13 May 2025
HYPNOVEL
Owner Roche Products Limited · classes 5
- Filed / designated
- 11 March 1970
- Valid until / renewal due
- 11 March 2025
ANEXATE
Owner Roche Products Limited · classes 5
- Filed / designated
- 19 August 1969
- Valid until / renewal due
- 19 August 2024
BACTRIM
Owner Roche Products Limited · classes 5
- Filed / designated
- 21 May 1968
- Valid until / renewal due
- 21 May 2023
LEXOTAN
Owner Roche Products Limited · classes 5
- Filed / designated
- 1 September 1967
- Valid until / renewal due
- 1 September 2022
FANSIDAR
Owner Roche Products Limited · classes 5
- Filed / designated
- 7 July 1967
- Valid until / renewal due
- 7 July 2022
VALIUM
Owner Roche Products Limited · classes 5
- Filed / designated
- 25 October 1961
- Valid until / renewal due
- 25 October 2026
RIVOTRIL
Owner Roche Products Limited · classes 5
- Filed / designated
- 20 November 1959
- Valid until / renewal due
- 20 November 2024
TENSILON
Owner Roche Products Limited · classes 5
- Filed / designated
- 1 June 1956
- Valid until / renewal due
- 1 June 2025
KONAKION
Owner Roche Products Limited · classes 5
- Filed / designated
- 27 February 1953
- Valid until / renewal due
- 27 February 2022
ROCHE
Owner Roche Products Limited · classes 5
- Filed / designated
- 30 January 1953
- Valid until / renewal due
- 30 January 2022
ROCHE
Owner Roche Products Limited · classes 1,3,5,16
- Filed / designated
- 12 May 1920
- Valid until / renewal due
- 12 May 2024
This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.
08 Ownership and control
People with significant control
Roche Holding (Uk) Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- England
- Legal authority
- Companies Act 2006
- Legal form
- Private Company Limited By Shares
- Place registered
- Companise House
- Registration number
- 03372540
- Notified
- 1 June 2016
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
09 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
10 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
11 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
12 Public procurement
Find a Tender links
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Regional Business Services Organisation, Procurement and Logistics Service · updated 3 July 2026
- Tender value
- £1,800,000,000
- Awards
- 214
NHS National Framework for the supply of Tocilizumab Injection
NHS England · updated 30 December 2025
- Tender value
- £188,195,000
- Awards
- 2
Baloxavir antiviral procurement
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · updated 6 November 2025
- Tender value
- Not supplied
- Awards
- 1
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · updated 6 October 2025
- Tender value
- £1,520,432,295
- Awards
- 3
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
13 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
14 Nature of business
Standard Industrial Classification
Other research and experimental development on natural sciences and engineering
15 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
4 procurement processes linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
16 Record timeline
Dates in the bulk record
- Confirmation statement
Latest confirmation statement made up to this date
- Accounts
Latest accounts made up to this date
- Incorporation
Company incorporated
17 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Annual employer reports linked by the exact source-supplied Companies House number.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Annual statement summaries linked by exact source company number.
Privacy-reduced candidate associations based on a unique exact name-and-postcode match.
Historic awards linked by exact source-supplied GB-COH company identifier.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.